» Articles » PMID: 31413599

Expansion of Typhi Clonal Lineages with Ampicillin Resistance and Reduced Ciprofloxacin Susceptibility in Eastern China

Overview
Publisher Dove Medical Press
Date 2019 Aug 16
PMID 31413599
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: This study was aimed to investigate the dynamics of antimicrobial resistance expansion among different lineages and isolates of . Typhi.

Materials And Methods: The . Typhi isolates were collected from the patients clinically suspected of typhoid fever in Eastern China during 2005-2017. All isolates were tested retrospectively for susceptibility to eight antimicrobials and the genes related to quinolone and ampicillin resistance, including and . The isolates were subtyped by PFGE.

Results: Of 140 isolates, all were susceptible to ciprofloxacin, cefotaxime, chloramphenicol, and trimethoprim-sulfamethoxazole, 95 (68%) were nalidixic acid resistant, and 74 (53%) were ampicillin resistant. The resistance to ampicillin and nalidixic acid was first observed in 2006. Among the 95 nalidixic acid-resistant . Typhi isolates, 62 possessed S83F mutation in  and 25 possessed D87Y mutation. All ampicillin-resistant isolates harbored gene . PFGE generated 47 distinguishable clonal lineages. Overall, 64% (89/140) belonged to seven prevalent lineages of clustering isolates. PFGE results illustrated the prevalence of nalidixic acid-resistant lineages increased steadily from 19% during 2005-2012 to 50% during 2013-2014, and thereafter to 74% during 2015-2017 and similar development of ampicillin-resistant lineages increased from 6% to 38%, and also to 39%.

Conclusion: The present study indicated the clonal expansion of . Typhi with ampicillin resistance and reduced ciprofloxacin susceptibility. The findings also suggested that the differential development of antimicrobial resistance to various antimicrobial agents in . Typhi, showing the rapid increase in ampicillin resistance and reduced ciprofloxacin susceptibility, and the high susceptibility to other traditional antimicrobial agents.

Citing Articles

Prevalence of Antimicrobial Resistance Genes in Typhi: A Systematic Review and Meta-Analysis.

Yusof N, Norazzman N, Mohd Zaidi N, Mohd Azlan M, Ghazali B, Ahmad Najib M Trop Med Infect Dis. 2022; 7(10).

PMID: 36288012 PMC: 9611315. DOI: 10.3390/tropicalmed7100271.


Prevalence of and Antimicrobial Resistance in Isolates from Food Animals - Six PLADs, China, 2019.

Cao T, Liu P, Li Y, Cui M, Zhang C, Wang Y China CDC Wkly. 2021; 3(24):514-517.

PMID: 34594924 PMC: 8393044. DOI: 10.46234/ccdcw2021.132.

References
1.
Cooke F, Wain J, Threlfall E . Fluoroquinolone resistance in Salmonella Typhi. BMJ. 2006; 333(7563):353-4. PMC: 1539082. DOI: 10.1136/bmj.333.7563.353-b. View

2.
Kato Y, Fukayama M, Adachi T, Imamura A, Tsunoda T, Takayama N . Multidrug-resistant typhoid fever outbreak in travelers returning from Bangladesh. Emerg Infect Dis. 2008; 13(12):1954-5. PMC: 2876753. DOI: 10.3201/eid1312.070422. View

3.
Vien L, Baker S, Phuong Thao L, Tu L, Thuy C, Nga T . High prevalence of plasmid-mediated quinolone resistance determinants in commensal members of the Enterobacteriaceae in Ho Chi Minh City, Vietnam. J Med Microbiol. 2009; 58(Pt 12):1585-1592. PMC: 2884939. DOI: 10.1099/jmm.0.010033-0. View

4.
Kumar Y, Sharma A, Mani K . Re-emergence of susceptibility to conventionally used drugs among strains of Salmonella Typhi in central west India. J Infect Dev Ctries. 2011; 5(3):227-30. DOI: 10.3855/jidc.1310. View

5.
Effa E, Lassi Z, Critchley J, Garner P, Sinclair D, Olliaro P . Fluoroquinolones for treating typhoid and paratyphoid fever (enteric fever). Cochrane Database Syst Rev. 2011; (10):CD004530. PMC: 6532575. DOI: 10.1002/14651858.CD004530.pub4. View